Indomo

Indomo

Private
Boston, MassachusettsHealthcare & Life Scienceshttp://www.indomotx.com

Last Round

Early Funding

Oct 30, 2025

Total Funding Raised

$25M

Company Overview

Indomo is a clinical-stage therapeutics company founded in 2021 and based in the Greater Boston area. The company is developing a novel treatment for inflammatory acne, which combines an injectable therapeutic with an intradermal self-injection device. This product is designed to allow patients to self-administer treatment for moderate to severe acne lesions at home, providing immediate relief and shifting the standard of care from a clinical setting. The company, which is currently in stealth mode, is backed by venture capital, having raised funds from investors including Mana Ventures, Polaris Partners, and Atomic Labs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B2C

Customer Profile

Hardware + Subscription

AI Layer

Non-AI

Keywords

acne therapeuticdrug-device combinationat-home acne treatmentself-injection deviceinflammatory acnepimple shotintradermal injectionacne injection penat-home dermatologyprescription acne treatmentdermatology therapeuticsintralesional injectionsclinical-stage therapeuticsMedTechdermal treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Indomo Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Indomo Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 30, 2025
VC RoundOct 21, 2024

Indomo Investors

Notable investors and investment history

InvestorRounds
GaingelsEarly Funding, VC Round
Foresite CapitalEarly Funding
Polaris PartnersVC Round, Early Funding
Atomic LabsVC Round, Early Funding
StoryHouse VenturesEarly Funding, VC Round
FORM Life VenturesEarly Funding
Mana VenturesEarly Funding, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 30, 2025

    $25M raised in early funding.

  • Oct 30, 2025

    Developing ClearPen, an investigational injectable therapy for inflammatory acne.

Indomo Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Indomo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Indomo's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2021
Last FundingOct 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.